Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and methane

sorafenib has been researched along with methane in 3 studies

Compound Research Comparison

Studies
(sorafenib)		Trials
(sorafenib)		Recent Studies (post-2010)
(sorafenib)		Studies
(methane)		Trials
(methane)		Recent Studies (post-2010) (methane)
6,5207305,25139,14224926,184

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Dehneshin, N; Farzad, F; Hasanzade, Z; Raissi, H1
Ahmed, AR; Alaaeldin, E; Allam, S; Elsadek, BE; Elsayed, MM; Mostafa, ME; Sarhan, HA; Shaykoon, MS1
Chen, S; Feng, Y; Guo, L; Hu, Y; Huang, H; Lian, L; Wan, L; Wen, Z; Xu, K; Yan, X; Yang, Q; Zhang, M1

Other Studies

3 other study(ies) available for sorafenib and methane

ArticleYear
Using molecular dynamics simulation to explore the binding of the three potent anticancer drugs sorafenib, streptozotocin, and sunitinib to functionalized carbon nanotubes.
    Journal of molecular modeling, 2019, May-14, Volume: 25, Issue:6

    Topics: Antineoplastic Agents; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Molecular Conformation; Molecular Dynamics Simulation; Nanotubes, Carbon; Sorafenib; Spectrum Analysis; Streptozocin; Sunitinib; Water

2019
Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma.
    International journal of nanomedicine, 2019, Volume: 14

    Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Body Weight; Carcinoma, Hepatocellular; Cell Proliferation; Drug Compounding; Drug Design; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liver; Liver Neoplasms; Male; Nanotubes, Carbon; Niacinamide; Rats, Wistar; Sorafenib; Spectroscopy, Fourier Transform Infrared; Static Electricity

2019
Multiwalled carbon nanotubes co-delivering sorafenib and epidermal growth factor receptor siRNA enhanced tumor-suppressing effect on liver cancer.
    Aging, 2021, 01-13, Volume: 13, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Delivery Systems; ErbB Receptors; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Mice; Mice, Nude; Nanotubes, Carbon; Neoplasm Transplantation; RNA, Small Interfering; Sorafenib

2021